Table 1 Demographics and clinical characteristics of COVID-19 patients on admission
Total (n = 252) | Febrile (n = 197) | Non-febrile (n = 55) | P value | |
|---|---|---|---|---|
Age, years | ||||
≤ 29 | 26 (10%) | 16 (8%) | 10 (18%) | 0.121 |
30–49 | 106 (42%) | 85 (43%) | 21 (38%) | |
50–69 | 94 (37%) | 73 (37%) | 21 (38%) | |
≥ 70 | 26 (10%) | 23 (12%) | 3 (5%) | |
Sex | ||||
Female | 110 (44%) | 82 (42%) | 28 (51%) | 0.231 |
Male | 141 (56%) | 114 (58%) | 27 (49%) | |
Temperature, °C | ||||
< 37.3 | 55 (22%) | 0 | 55 (100%) | < 0.001 |
37.3–38.0 | 104 (41%) | 104 (53%) | 0 | |
38.1–39 | 80 (32%) | 80 (41%) | 0 | |
39.1–41 | 13 (5%) | 13 (7%) | 0 | |
Signs and symptoms | ||||
Cough | 177 (70%) | 145 (74%) | 32 (58%) | 0.027 |
Myalgia | 42 (17%) | 33 (17%) | 9 (16%) | 0.946 |
Cephalalgia | 22 (9%) | 12 (6%) | 10 (18%) | 0.005 |
Sputum | 105 (42%) | 92 (47%) | 13 (24%) | 0.002 |
Hemoptysis | 4 (2%) | 4 (2%) | 0 | 0.579 |
Diarrhea | 28 (11%) | 23 (12%) | 5 (9%) | 0.590 |
Dyspnea | 35 (14%) | 28 (14%) | 7 (13%) | 0.768 |
Poor appetite | 140 (56%) | 117 (59%) | 23 (42%) | 0.020 |
Comorbidity | ||||
Hypertension | 48 (19%) | 39 (20%) | 9 (16%) | 0.566 |
Diabetes | 18 (7%) | 14 (7%) | 4 (7%) | 1.000 |
Digestive tract disease | 4 (2%) | 2 (1%) | 2 (4%) | 0.444 |
Cardiovascular disease | 10 (4%) | 8 (4%) | 2 (4%) | 1.000 |
Cerebrovascular disease | 3 (1%) | 3 (2%) | 0 | 1.000 |
Malignancy | 4 (2%) | 2 (1%) | 2 (4%) | 0.444 |
Liver disease | 6 (2%) | 3 (2%) | 3 (5%) | 0.234 |
Chronic lung disease | 8 (3%) | 5 (3%) | 3 (5%) | 0.512 |
Treatments and outcomes | ||||
Oxygen supplementation | 200 (79%) | 157 (80%) | 43 (78%) | 0.806 |
Mechanical ventilation | 10 (4%) | 9 (5%) | 1 (2%) | 0.594 |
ECMO | 4 (2%) | 4 (2%) | 0 | 0.579 |
Critically ill | 52 (21%) | 40 (20%) | 12 (22%) | 0.806 |
ARDS | 21 (8%) | 17 (9%) | 4 (7%) | 0.963 |
ICU admission | 43 (17%) | 34 (17%) | 9 (16%) | 0.876 |
Mortality | 6 (2%) | 6 (3%) | 0 | 0.344 |